These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26774400)

  • 1. Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studies.
    Aneke-Nash CS; Dominguez-Islas C; Bůžková P; Qi Q; Xue X; Pollak M; Strickler HD; Kaplan RC
    Growth Horm IGF Res; 2016 Feb; 26():11-6. PubMed ID: 26774400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults.
    Aneke-Nash CS; Parrinello CM; Rajpathak SN; Rohan TE; Strotmeyer ES; Kritchevsky SB; Psaty BM; Bůžková P; Kizer JR; Newman AB; Strickler HD; Kaplan RC
    J Am Geriatr Soc; 2015 May; 63(5):902-9. PubMed ID: 25989565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
    Ong K; Kratzsch J; Kiess W; Costello M; Scott C; Dunger D
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4266-9. PubMed ID: 11095465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.
    Frystyk J; Grønbaek H; Skjaerbaek C; Flyvbjerg A; Orskov H; Baxter RC
    Endocrinology; 1998 Oct; 139(10):4286-92. PubMed ID: 9751511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
    Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.